Trials / Recruiting
RecruitingNCT06755671
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,500 (estimated)
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to evaluate if Danning Tablets are effective in alleviating dyspepsia in patients with any of the following digestive symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation. The main questions it aims to answer are: How effective are Danning Tablets for patients with indigestion symptoms? What are the impact factors (e.g. severity of conditions, demographic features, dose and length of treatment etc.) of the efficacy of Danning Tablets for indigestion patients? Participants already taking Danning Tablets as part of their regular medical care for indigestion will take questionnaires by the end of two weeks and four weeks respectively from the start of their treatment.
Conditions
- Indigestion
- Dyspepsia
- Bloating
- Loss of Appetite
- Reflux Acid
- Constipation
- Upper Abdominal Pain
- Functional Dyspepsia
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danning Tablet | Danning Tablet is the only exposure in this observational study. |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2025-01-01
- Last updated
- 2025-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06755671. Inclusion in this directory is not an endorsement.